Skip to main content
logo
MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
1.220
-0.060 (-4.69%)
At close: Aug 28, 2026, 4:00 PM EDT
1.213
-0.008 (-0.61%)
After-hours: Aug 28, 2026, 7:30 PM EDT

MaxCyte Revenue

MaxCyte had revenue of $7.27M in the quarter ending June 30, 2026, a decrease of -14.53%. This brings the company's revenue in the last twelve months to $31.05M, down -13.15% year-over-year. In the year 2025, MaxCyte had annual revenue of $33.03M, down -14.50%.

Revenue (ttm)
$31.05M
Revenue Growth
-13.15%
P/S Ratio
4.05
Revenue / Employee
$341,220
Employees
91
Market Cap
125.91M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202533.03M-5.60M-14.50%
Dec 31, 202438.63M-2.66M-6.44%
Dec 31, 202341.29M-2.97M-6.72%
Dec 31, 202244.26M10.37M30.59%
Dec 31, 202133.89M7.73M29.52%
Dec 31, 202026.17M4.55M21.04%
Dec 31, 201921.62M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Inogen354.30M
Quanterix153.41M
Owlet114.41M
Pulmonx87.44M
LENSAR60.26M
Apyx Medical58.42M
electroCore36.97M
Hyperfine16.54M
Revenue Rankings

MXCT News

More News